Jones, R N <br/><br/>
Antimicrobial activity of isepamicin (SCH21420, 1-N-HAPA gentamicin B) combinations with cefotaxime, ceftazidime, ceftriaxone, ciprofloxacin, imipenem, mezlocillin and piperacillin tested against gentamicin-resistant and susceptible gram-negative bacilli and enterococci.  [electronic resource] 

 -  Journal of chemotherapy (Florence, Italy)  Oct 1991 
 - 289-94 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1120-009X 
<br/><br/><label>Standard No.: </label>10.1080/1120009x.1991.11739108  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cefotaxime--pharmacology<br/>Ceftazidime--pharmacology<br/>Culture Media<br/>Drug Interactions<br/>Drug Resistance, Microbial<br/>Drug Synergism<br/>Drug Therapy, Combination--pharmacology<br/>Enterobacteriaceae--drug effects<br/>Enterococcus--drug effects<br/>Gentamicins--pharmacology<br/>Gram-Negative Bacteria--drug effects<br/>Imipenem--pharmacology<br/>Mezlocillin--pharmacology<br/>Piperacillin--pharmacology<br/>Pseudomonas--drug effects